Retatrutide is a triple receptor agonist that simultaneously targets GLP-1, GIP and glucagon pathways, making it one of the most advanced peptides currently investigated in metabolic research. By influencing appetite regulation, energy expenditure and metabolic signalling through three complementary mechanisms, it provides researchers with a broader understanding of body composition and energy balance. Its novel multi-receptor design continues to attract significant interest in next-generation metabolic and obesity research.

The Aesthetic Standard™

Every Aesthetic Labs product is manufactured to rigorous research-grade specifications and independently tested to deliver exceptional purity, consistency and quality—because confidence in your research begins with confidence in your materials.